Lilly’s Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...
Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback